• Founded: 2016
  • Location: Boston, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Therapy area: Cholera
  • Drug types: INF, PED
  • Lead product: ProphaLytic-VC
  • Product link:

Short description:


Drug notes:

Contact us to add description:

Long description:

PhagePro is developing phage treatments to solve the globe’s largest health disparities and antibiotic resistance. As bacteria build resistance to antibiotics, alternative killing methods are required. Phages are natural hunters of bacteria. PhagePro is exploiting this power of phages to reduce the burden of antimicrobial resistance in emerging markets. As the phages only target bacteria, they are safe to humans and more specific than antibiotics. In addition, PhagePro is prioritizing stakeholder relationships to understand needs and incorporate them into their strategies to increase adoption on a global scale.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy